94 results on '"Fuller, Deborah H."'
Search Results
52. PROLONGED SARS-CoV-2 VIRAL BURDEN IN SIV-SARS-CoV-2 COINFECTED MACAQUES.
53. INNATE IMPAIRMENT DURING SIV INFECTION ALTERS ZIKV VIRAL PATHOGENESIS.
54. Rapid Loss of Th17 Cells after SIV Infection May Underlie Mucosal Dysfunction
55. A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine
56. DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4+ T cells, but few subdominant epitope-specific CD8+ T cells
57. Oral Immunization with a Live Coxsackievirus/HIV Recombinant Induces Gag p24-Specific T Cell Responses
58. GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates
59. Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases
60. Optimizing Particle-Mediated Epidermal Delivery of an Influenza DNA Vaccine in Ferrets.
61. `Omics Investigations of HIV and SIV Pathogenesis and Innate Immunity.
62. Multispecific Vaccine-Induced Mucosal Cytotoxic TLymphocytes Reduce Acute-Phase Viral Replication but Fail inLong-Term Control of Simian Immunodeficiency VirusSIVmac239
63. Differences Between T Cell Epitopes Recognized After Immunization and After Infection
64. Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239
65. Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin fromEscherichia coliAre Strong Adjuvants for DNA Vaccines
66. Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen
67. Comparison of Immunity Generated by Nucleic Acid-, MF59-, and ISCOM-Formulated Human Immunodeficiency Virus Type 1 Vaccines in Rhesus Macaques: Evidence for Viral Clearance
68. Induction and characterization of humoral and cellular immune responses elicited via gene gun-mediated nucleic acid immunization
69. Use of DNAs Expressing HIV-1 Env and Noninfectious HIV-1 Particles to Raise Antibody Responses in Mice
70. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA
71. Oral Immunization with a Live Coxsackievirus/HIV Recombinant Induces Gag p24-Specific T Cell Responses.
72. Dual R108K and G189D Mutations in the NS1 Protein of A/H1N1 Influenza Virus Counteract Host Innate Immune Responses.
73. Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches.
74. Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin from Escherichia coliAre Strong Adjuvants for DNA Vaccines
75. Replication-Competent ΔNS1 Influenza A Viruses Expressing Reporter Genes.
76. Rational Design of a Pan-Coronavirus Vaccine Based on Conserved CTL Epitopes.
77. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo.
78. Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture.
79. Development of Monoclonal Antibodies for Detection of Conserved and Variable Epitopes of Large Protein of Rabies Virus.
80. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
81. The Antimalarial Compound Atovaquone Inhibits Zika and Dengue Virus Infection by Blocking E Protein-Mediated Membrane Fusion.
82. Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers.
83. Rapid Loss of Th17 Cells after SIV Infection May Underlie Mucosal Dysfunction.
84. Enhancement of immunodeficiency virus-specific immune responses in DNA-immunized rhesus macaques
85. Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit
86. DNA vaccines: A novel approach to immunization
87. Multispecific Vaccine-Induced Mucosal Cytotoxic T Lymphocytes Reduce Acute-Phase Viral Replication but Fail in Long-Term Control of Simian Immunodeficiency Virus SIV mac239.
88. A novel tetrameric gp350 1–470 as a potential Epstein–Barr virus vaccine.
89. DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4+ T cells, but few subdominant epitope-specific CD8+ T cells
90. Chronic innate immune impairment and ZIKV persistence in the gastrointestinal tract during SIV infection in pigtail macaques.
91. Macaque-human differences in SARS-CoV-2 Spike antibody response elicited by vaccination or infection.
92. Optimizing particle-mediated epidermal delivery of an influenza DNA vaccine in ferrets.
93. Particle-mediated DNA vaccination of mice, monkeys and men: looking beyond the dogma.
94. Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.